> 首页 > 产品 > 一抗 > 其他 > Anti-ANG2 & VEGFA Reference Antibody (Faricimab)

Anti-ANG2 & VEGFA Reference Antibody (Faricimab)

The purity of Anti-ANG2 & VEGFA Reference Antibody (Faricimab) is more than 95%, determined by SEC-HPLC.
Anti-ANG2 & VEGFA Reference Antibody (Faricimab)-Proliferation inhibition using HUVEC Cell. The maximum proliferation inhibition rate is about 80%
Anti-ANG2 & VEGFA Reference Antibody (Faricimab) Luciferase Assay was evaluated using VEGFR2-NF-AT HEK293 Cell. The IC50 was approximately 8.449 nM .
Immobilized VEGFA Protein at 2 µg/mL can bind Anti-ANG2 & VEGFA Reference Antibody (Faricimab).
Affinity constant of 1.25E-10M as determined in BLI assay.（Human ANGPT2, His Tag）
The detected molecular weight of Anti-ANG2 & VEGFA Reference Antibody (Faricimab) is 146.16 kDa.

产品详情
实验流程

Product Information
Application Applications Legend: E=ELISA WB=Western Blotting IHC=Immunohistochemistry IHC-P=Immunohistochemistry (Paraffin) IP=Immunoprecipitation IF=Immunofluorescence IC=Immunochemistry ICC=Immunocytochemistry FC=Flow Cytometry DB=Dot Blot	Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession	Q9UID3 & P15692
Reactivity	Human
Clonality	Bispecific
Isotype	IgG-like

Additional Information
Target/Specificity	VEGFA,ANGPT2
Expression system	CHO

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.